Summary
Overview
Work History
Education
Certification
Additional Information
Timeline
Generic

Sridhar bhogavalli

Senior Scientist
Waukegan

Summary

Fourteen years of analytical experience in Q.C and R&D, working with sterile injectable dosage forms from simple to complex. Two years of academic research experience in purification, characterization of proteins using SDS-PAGE, agarose gel electrophoresis. Analytical method development for peptides, suspensions, emulsions, liposomes, and microsphere based injectable drug products as per USP & ICH guidelines. Author & review method validation protocols, reports, SOPs, and eCTD sections for ANDA. Proficiency with Empower 3 & electronic (eLN) documentation. INSTRUMENTAL SKILLS HPLC (Agilent/Waters) & UPLC (Waters H Class) with detectors from PDA to ELSD, CAD. GC, USP II& IV Dissolution apparatus, UV-Vis spectrometer, KF (Water content), Near & Far-UV CD, Mastersizer (Malvern 3000), FTIR and Zetasizer.

Overview

17
17
years of professional experience
4
4
Certifications

Work History

Senior Scientist

Hospira, Pfizer Inc
Lake Forest
05.2020 - Current
  • Lead the nitrosamine remediation of several on-market sterile injectable products, from risk assessment to excipient evaluation for Nitrite content.
  • Lead the early phase analytical method development, pre formulation (Solubility Screen) and formulation process (particle size) for simple solutions to complex long-acting sterile injectable dosage forms (suspensions, emulsions, peptides).

PAT (Process Analytical Technology) support with inline/offline measurement of Particle size & phosphate content in the pilot scale manufacture of liposome based Covid-19 placebo, in addition to formulation support under aggressive timeline

  • Key supporting role in establishment of LAR platform using a model drug (microsphere, gel and oil) through development of different analytical methods (drug load, residual solvents, particle size, moisture content, in vitro dissolution) for formulation screening
  • Sameness study analytical support for peptides that include CD (Near & Far UV), Intrinsic Fluorescence and AF4
  • Played a critical role in approval of complex emulsion based ANDA through development of invitro dissolution method as part of BE
  • Authoring & peer review of eCTD sections as part of regulatory ANDA submissions
  • Author, review of method validation protocols, reports.

Scientist

Innopharma & Hospira, Pfizer Inc
08.2012 - 04.2020
  • Early phase analytical method development (Assay/RS, residual solvents, Dissolution) support for niche & complex long-acting sterile injectable dosage forms like suspensions, emulsions, peptides, and liposomes
  • Experienced in development of reverse phase UPLC methods for peptides with critical impurity separation and SEC to determine peptide aggregation
  • Efficient in handling/providing support for high priority complex projects with short timeline, which includes method development, prevalidation and formulation support
  • Formulation support for ANDA and 505(b)(2) filings with respect to Assay & Impurity analysis, filter compatibility and tubing studies, admixture studies by HPLC and head space oxygen analysis by GC
  • Played a critical role in first to filing of complex ophthalmic emulsion based ANDA through development of invitro dissolution method in a very short period
  • Author & review of analytical method development reports, method validation protocols, reports
  • Experienced in reviewing extractable& leachable (E&L) stability data for ANDA submissions.

Chemist

Oakwood Laboratories
Oakwood Village
12.2011 - 08.2012
  • Lead & supported the analytical method development (Assay/RS, residual solvents) prevalidation, validation studies for sterile injectable sustained release drug products that are developed on PLGA based microsphere-based drug delivery technology
  • Supported the routine analytical testing that include in-process, finished product stability testing following the cGMP guidelines and standard operating procedures
  • Author, review of method validation protocols, reports.

Scientist

Ben Venue Laboratories
Bedford
07.2010 - 12.2011
  • Assisted with HPLC assay method development for API, drug product by performing prevalidation studies and executed the method validations
  • Independently lead the development, validation of analytical method to quantitate residual solvents in API and Liposome based product using GC headspace
  • Routine testing & analytical support for ANDA batches that include API, In-process and final product release testing
  • Assisted with the cleaning study method development for a cytotoxic injectable drug product (based on rinse and swab recovery technique)
  • Maintenance and troubleshooting of the analytical instruments like HPLC, GC & KF.

Chemist (Q.C)

Ben Venue Laboratories
Bedford
12.2007 - 07.2010
  • Routine analytical testing of raw materials (API), in process and finished injectable drug products using analytical instruments like HPLC, GC following the cGMP guidelines and standard operating procedures
  • Handled, managed complex analytical raw material projects that include schedule, coordinate, and prioritize based on the production schedule
  • (Always submitted the regular and complex raw material projects right first time without any deviations/investigations)
  • Trained new Chemists in getting acquainted with analytical instruments like HPLC, GC, KF, pH meter and UV-VIS spectroscopy
  • Provided technical support to Quality Control & Quality Assurance in OOS Investigations, root cause analysis
  • Peer review of analytical data and participation in the Quality improvement process.

Teaching Assistant

Cleveland State University
Cleveland
01.2006 - 12.2007
  • Worked as an instructor for Undergraduate Chemistry Students to tutor, help with the General chemistry laboratory course
  • Prepared, conducted, and graded exams, quizzes for Undergraduate students.

Research Assistant

Cleveland Clinic Foundation
Cleveland
07.2006 - 08.2006
  • Media preparation for cell culture, isolation of DNA, cell transformation and review of literature on Topoisomerase II enzymes.

Education

EMBA - undefined

Quantic School of Business & Technology

M.S - Chemistry

Cleveland State University

B.S - Pharmacy

College of Pharmacy, Andhra University

Certification

Lean Six Sigma Green Belt, SSGI, Credential ID # 24231227.

Additional Information

  • HONORS , Graduate Teaching Assistantship (2006-2007), Cleveland State University.

Timeline

Senior Scientist

Hospira, Pfizer Inc
05.2020 - Current

Scientist

Innopharma & Hospira, Pfizer Inc
08.2012 - 04.2020

Chemist

Oakwood Laboratories
12.2011 - 08.2012

Scientist

Ben Venue Laboratories
07.2010 - 12.2011

Chemist (Q.C)

Ben Venue Laboratories
12.2007 - 07.2010

Research Assistant

Cleveland Clinic Foundation
07.2006 - 08.2006

Teaching Assistant

Cleveland State University
01.2006 - 12.2007

EMBA - undefined

Quantic School of Business & Technology

M.S - Chemistry

Cleveland State University

B.S - Pharmacy

College of Pharmacy, Andhra University
Sridhar bhogavalliSenior Scientist